Czechia· CZ-0001328

DOPEGYT

A methyldopa (levorotatory) product containing methyldopa sesquihydrate, registered in Czechia by Egis Pharmaceuticals PLC, Budapešť. The same ATC class is registered in 10 of our 19 countries.

ATC C02AB01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedDOPEGYTATCC02AB01REGISTER NO.CZ-0001328PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Methyldopa (levorotatory) is registered in 10 of 19 countries.

Countries holding a registration under ATC C02AB01 (methyldopa (levorotatory)), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Methyldopa (levorotatory) · ATC C02AB01

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methyldopa (levorotatory) costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Methyldopa (levorotatory) · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • IT Italy$0.42
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
METHYLDOPA SESQUIHYDRATE
Manufacturer
Egis Pharmaceuticals PLC, Budapešť
Country
Czechia (CZ)
ATC code
C02AB01
ATC class
Methyldopa (levorotatory)
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0001328
    50
    CZK 239.74

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

182 interactions on record for methyldopa (levorotatory).

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methyldopa (levorotatory) · interactions on record

182 records

  • 8 severe
  • 95 moderate
  • 10 minor
  • 69 info

Most severe, free to view

  • ProcarbazineL01XB01severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • OzanimodL04AA38severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methyldopa (levorotatory) in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methyldopa (levorotatory) products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Aldometil
  • Belgium · Aldomet
  • Bulgaria · Допегит
  • Cyprus · Dopamet, Methyldopa Remedica
  • Germany · Dopegyt, Methyldopa Stada
  • Denmark · Methyldopa Macure
  • Spain · Aldomet, Aldomet Forte
  • Finland · Methyldopa Macure
  • France · Aldomet
  • United Kingdom (Northern Ireland) · Methyldopa, Methyldopa Accord-Uk
  • Hungary · Dopegyt
  • Italy · Aldomet
  • Lithuania · Dopegyt
  • Latvia · Dopegyt
  • Malta · Methyldopa Remedica
  • Netherlands · L-Methyldopa Teva, Methyldopa Cf
  • Norway · Methyldopa Macure
  • Poland · Dopegyt
  • Portugal · Aldomet, Aldomet Forte
  • Romania · Dopegyt
  • Sweden · Methyldopa Macure
  • Slovakia · Dopegyt

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0546aab3-b512-474b-b65b-c05f96131c78
GET /v1/drugs/0546aab3-b512-474b-b65b-c05f96131c78?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "250MG",
  "pack_size": "50",
  "substance": "METHYLDOPA SESQUIHYDRATE",
  "cz_kod_sukl": "0001328",
  "product_type": "CH",
  "substance_codes": "11523",
  "registration_state": "R",
  "registration_number": "58/256/70-S/C"
}

See everything about methyldopa (levorotatory).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.